Onkológia 1/2018

Systemic treatment of metastatic renal cell carcinoma after failure of the first line of treatment

renal cell carcinoma, tyrosine kinase inhibitor, mTOR inhibitor, target therapy

Keywords: karcinóm obličky, inhibítory tyrozínkinázy, mTOR inhibítor, cielená terapia